4/A
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-26-002893
General Counsel bought 25,000 shares at $1.89 ($47,250)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anderman Jonathan General Counsel | 2026-04-29 | Purchase | +25,000 | $1.89 | $47,250 | 196,000 | D |
| Open-market purchases · 25,000 sh · avg $1.89 · $47,250 | |||||||
Loading xslF345X06/ownership.xml…